ArticleDiagnostics (Basel, Switzerland)2022

Impedimetric Detection Based on Label-Free Immunoassay Developed for Targeting Spike S1 Protein of SARS-CoV-2.

Arzum Erdem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.